These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35845404)

  • 21. ROS-responsive drug delivery systems for biomedical applications.
    Tao W; He Z
    Asian J Pharm Sci; 2018 Mar; 13(2):101-112. PubMed ID: 32104383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near-infrared photoresponsive drug delivery nanosystems for cancer photo-chemotherapy.
    Wang X; Xuan Z; Zhu X; Sun H; Li J; Xie Z
    J Nanobiotechnology; 2020 Aug; 18(1):108. PubMed ID: 32746846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH- and enzyme-triggered drug release as an important process in the design of anti-tumor drug delivery systems.
    Cao Z; Li W; Liu R; Li X; Li H; Liu L; Chen Y; Lv C; Liu Y
    Biomed Pharmacother; 2019 Oct; 118():109340. PubMed ID: 31545284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
    Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
    J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
    Li L; Yang WW; Xu DG
    J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of Novel and Nanostructured Drug Delivery Systems for the Treatment of Oral Cavity Diseases.
    Hosseinpour-Moghadam R; Mehryab F; Torshabi M; Haeri A
    Clin Ther; 2021 Dec; 43(12):e377-e402. PubMed ID: 34844769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-Ray-Induced Drug Release for Cancer Therapy.
    Liu H; Zhao J; Xue Y; Zhang J; Bai H; Pan S; Peng B; Li L; Voelcker NH
    Angew Chem Int Ed Engl; 2023 Sep; 62(39):e202306100. PubMed ID: 37278399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Starch-based materials for drug delivery in the gastrointestinal tract-A review.
    Boldrini DE
    Carbohydr Polym; 2023 Nov; 320():121258. PubMed ID: 37659802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors.
    Fathi M; Abdolahinia ED; Barar J; Omidi Y
    Nanomedicine (Lond); 2020 Sep; 15(22):2171-2200. PubMed ID: 32912045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
    Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
    Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smart Bacteria-Responsive Drug Delivery Systems in Medical Implants.
    Yang Y; Jiang X; Lai H; Zhang X
    J Funct Biomater; 2022 Oct; 13(4):. PubMed ID: 36278642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near infrared light-triggered nanoparticles using singlet oxygen photocleavage for drug delivery systems.
    Dariva CG; Coelho JFJ; Serra AC
    J Control Release; 2019 Jan; 294():337-354. PubMed ID: 30592981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.
    Zhang J; Lin Y; Lin Z; Wei Q; Qian J; Ruan R; Jiang X; Hou L; Song J; Ding J; Yang H
    Adv Sci (Weinh); 2022 Feb; 9(5):e2103444. PubMed ID: 34927373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrageenan: A Wonder Polymer from Marine Algae for Potential Drug Delivery Applications.
    Qureshi D; Nayak SK; Maji S; Kim D; Banerjee I; Pal K
    Curr Pharm Des; 2019; 25(11):1172-1186. PubMed ID: 31465278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Delivery Systems with a "Tumor-Triggered" Targeting or Intracellular Drug Release Property Based on DePEGylation.
    Ren Z; Liao T; Li C; Kuang Y
    Materials (Basel); 2022 Jul; 15(15):. PubMed ID: 35955225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme responsive drug delivery systems in cancer treatment.
    Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications.
    Shen X; Li T; Xie X; Feng Y; Chen Z; Yang H; Wu C; Deng S; Liu Y
    Front Bioeng Biotechnol; 2020; 8():381. PubMed ID: 32432092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy.
    Kim MW; Kwon SH; Choi JH; Lee A
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
    Lv W; Cao M; Liu J; Hei Y; Bai J
    Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.